...
首页> 外文期刊>Patient Preference and Adherence >Ten lessons learned from conducting an adherence intervention trial
【24h】

Ten lessons learned from conducting an adherence intervention trial

机译:进行依从性干预试验的十个经验教训

获取原文
           

摘要

Abstract: Clinical practice research provides a unique opportunity to care for a diverse patient population in various health care system settings. Federal study of Adherence to Medications in the Elderly (FAME) was the first prospective observational and randomized controlled trial to implement effective strategies to enhance medication adherence and health outcomes in older patients using polypharmacy. Ten lessons learned from conducting this adherence intervention trial are described: (1) Link the trial to existing clinical work, (2) Begin with a thorough understanding of medication adherence, (3) Ensure that trial highlights individualized intervention, (4) Tailor inclusion criteria and study duration to target population, (5) Employ a range of outcomes linked to meaningful clinical effects, (6) Win the support of the multidisciplinary team and the administration, (7) Promote team work, (8) Consider the potential limitations, (9) Seize the grant opportunities, and (10) Share the findings.
机译:摘要:临床实践研究提供了一个独特的机会,可以在各种医疗保健系统设置中为不同的患者群体提供护理。联邦关于老年人对药物依从性的研究(FAME)是第一个前瞻性观察性和随机对照试验,旨在实施有效策略以提高使用多药治疗的老年患者的药物依从性和健康结果。描述了进行依从性干预试验的十个经验教训:(1)将试验与现有临床工作联系起来;(2)从对药物依从性的透彻理解开始;(3)确保试验突出个性化干预;(4)量身定制针对目标人群的标准和研究持续时间,(5)取得与有意义的临床效果相关的一系列结果,(6)赢得多学科团队和行政部门的支持,(7)促进团队合作,(8)考虑潜在的局限性,(9)抓住拨款机会,以及(10)分享调查结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号